Pharmacokinetics of bevacizumab in haemodialysis

被引：1
|
作者：
Garnier-Viougeat, Nathalie [1 ]
Rixe, Olivier
Paintaud, Gilles
Ternant, David
Degenne, Danielle
Mouawad, Roger
Deray, Gilbert
Izzedine, Hassane
机构：
[1] Hop La Pitie Salpetriere, Dept Clin Oncol, Paris, France
[2] Hop La Pitie Salpetriere, Dept Nephrol, Paris, France
[3] Univ Tours, EA 3853, Tours, France
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2007年 / 22卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：975 / 975
页数：1
相关论文
共 50 条
  • [21] Pharmacokinetics of Intravitreal Bevacizumab (Avastin) in Rabbits
    Sinapis, C.
    Routsias, J.
    Sinapis, D.
    Sinapis, A.
    Sinapi, V.
    Pantopoulou, A.
    Baltatzis, S.
    Patsouris, E.
    Perrea, D.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [22] Pharmacokinetics of an antifibrotic agent, pirfenidone, in haemodialysis patients
    M. Taniyama
    S. Ohbayashi
    M. Narita
    R. Nakazawa
    S. Hasegawa
    N. Azuma
    S. Teraoka
    K. Ota
    S. Yamauchi
    S. B. Margolin
    European Journal of Clinical Pharmacology, 1997, 52 : 77 - 78
  • [23] Pharmacokinetics and administration method of gentamicin in a patient on haemodialysis
    Hiraki, Yoichi
    Hiraike, Mikako
    Nagano, Masahisa
    Ozono, Yukari
    Manabe, Kenichi
    Misumi, Nobuhiro
    Tsuji, Yasuhiro
    Kamimura, Hidetoshi
    Karube, Yoshiharu
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2012, 44 (08) : 630 - 634
  • [24] Pharmacokinetics of amlodipine in hypertensive patients undergoing haemodialysis
    G. Kungys
    H. Naujoks
    C. Wanner
    European Journal of Clinical Pharmacology, 2003, 59 : 291 - 295
  • [25] Pharmacokinetics of pazopanib administered in combination with bevacizumab
    Diane-Charlotte Imbs
    Sylvie Négrier
    Philippe Cassier
    Antoine Hollebecque
    Andrea Varga
    Ellen Blanc
    Thierry Lafont
    Bernard Escudier
    Jean-Charles Soria
    David Pérol
    Etienne Chatelut
    Cancer Chemotherapy and Pharmacology, 2014, 73 : 1189 - 1196
  • [26] Influence of continuous venovenous haemodialysis on midazolam pharmacokinetics
    Bolon, M.
    Bastien, O.
    Flamens, C.
    Paulus, S.
    Boulieu, R.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2001, 15 : 114 - 114
  • [27] Pharmacokinetics and dosage adjustment of rifabutin in a haemodialysis patient
    Bassilios, N
    Launay-Vacher, V
    Hamani, AA
    Masias, L
    Peytavin, G
    Fau, JB
    Deray, G
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 (03) : 531 - 532
  • [28] Pharmacokinetics and distributions of bevacizumab by intravitreal injection of bevacizumab-PLGA microspheres in rabbits
    Zhuo Ye
    Yan-Li Ji
    Xiang Ma
    Jian-Guo Wen
    Wei Wei
    Shu-Man Huang
    International Journal of Ophthalmology, 2015, (04) : 653 - 658
  • [29] Pharmacokinetics and distributions of bevacizumab by intravitreal injection of bevacizumab-PLGA microspheres in rabbits
    Ye, Zhuo
    Ji, Yan-Li
    Ma, Xiang
    Wen, Jian-Guo
    Wei, Wei
    Huang, Shu-Man
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2015, 8 (04) : 653 - 658
  • [30] Effect of impaired renal function and haemodialysis on the pharmacokinetics of aprepitant
    Bergman, AJ
    Marbury, T
    Fosbinder, T
    Swan, S
    Hickey, L
    Bradstreet, TE
    Busillo, J
    Petty, KJ
    Aiyer, KJV
    Constanzer, M
    Huskey, SEW
    Majumdar, A
    CLINICAL PHARMACOKINETICS, 2005, 44 (06) : 637 - 647
12345